MY ACCOUNT | NEWSLETTER |

Digitail and CDMV Announce a Strategic Partnership to Elevate Veterinary Clinic Operations and Patient Outcomes


Digitail, the industry’s leading AI-native veterinary practice information management system (PIMS), today announced a new integration and go-to-market partnership with CDMV, Canada’s leading distributor and service provider for animal health professionals. The partnership connects Digitail’s cloud-based operating system with CDMV to automate product catalogs and pricing, reduce administrative work, and improve patient outcomes.

With the new CDMV integration, users can now import product catalogs and see real time up-to-date pricing directly in Digitail — no more manual entry and updates required. This means invoices match reality, margins are protected, and the risk of losing money to outdated costs or errors disappears. By unifying purchasing, inventory, treatment plans, and billing in one workflow, clinic teams save significant time on admin and keep their focus where it belongs: patient care.

Key benefits for clinics

  • Always-accurate pricing: CDMV product costs sync in real time within Digitail, keeping invoices correct and margins protected. Clinics gain confidence knowing they’re charging accurately and not leaving revenue behind.
  • Smarter inventory control: Clinics can place orders directly from CDMV through Digitail—whether manually or via automated ordering—helping maintain essential stock while reducing waste and unnecessary spend. Teams avoid the stress of stock-outs and feel assured they can deliver consistent, reliable care.
  • Streamlined workflows: Purchase orders flow seamlessly from treatment plan to invoice to fulfillment, reducing administrative effort and errors. With fewer manual tasks, staff can focus more on patients, strengthening client trust and care quality.

“Veterinary teams deserve tools that lighten their heavy administrative load,” said Sebastian Gabor, CEO and Co-Founder of Digitail. “By combining CDMV’s distribution expertise with Digitail’s AI-native platform, we’re one step closer to our mission of keeping veterinary teams away from computers, seeing more pets, and making it home on time."

— Sebastian Gabor, Co-Founder and CEO, Digitail

“CDMV’s distinctive value proposition is anchored in a strong dedication to delivering innovative, high-performance solutions tailored to the evolving needs of animal health professionals across Canada. Our collaboration with Digitail is fully aligned with this commitment.”

— Serge Varin, President and CEO, CDMV

Why this matters for veterinary teams

  • One source of truth: Live CDMV catalog and pricing inside Digitail’s AI-native PIMS keeps costs, margins, and on-hand counts accurate where care happens—not in spreadsheets.
  • More time for medicine: No double entry or manual reconciliations; fewer backorder surprises. Clinicians see clear, real-time availability at the point of care.
  • Smarter decisions: Unified analytics across usage, pricing, and purchasing surface savings opportunities, flag protocol gaps, and trigger smarter reorders.

Availability

The Digitail–CDMV integration will be available to shared customers in Canada beginning October 15, 2025. Clinics can sign up by contacting their Digitail Customer Success Manager or CDMV Account Executive. Find out more information by visiting this link.

About Digitail

Digitail is an industry-leading, cloud-based, AI-native Veterinary PIMS trusted by more than 10,000 veterinary professionals worldwide. Its mission is to keep veterinarians away from the computer and help them see more patients. By eliminating admin work and streamlining operations, Digitail enables clinics to grow capacity, boost efficiency, and improve outcomes.

About CDMV

CDMV is the Canadian leader in distribution and solutions partner dedicated to animal health professionals, providing a comprehensive catalog of pharmaceuticals, supplies, diets, and equipment alongside digital services that simplify procurement and inventory management.


Source: www.cdmv.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Rescue therapy with doxorubicin-based chemotherapy for relapsing or refractory feline lymphoma: a retrospective study of 23 cases

Like0
Dislike0

Treatment of demodicosis in dogs: 2011 clinical practice guidelines

Like0
Dislike0

Antibiotics in Canadian poultry productions and anticipated alternatives

Like0
Dislike0

How a Better Bile Acid Could Keep C. diff at Bay

Like0
Dislike0

Sleepypod Launches Clickit Range, a Car Safety Harness Designed and Tested to Protect a Broader Spectrum of Canine Body Types

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top